DM
SLDB icon

Deerfield Management’s Solid Biosciences SLDB Stock Holding History

Deerfield Management’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,743,398
Closed -$9.89M – 623
2024
Q2 		$9.89M Sell
1,743,398
-517,000
-23% -$4.63M 0.16% 67
2024
Q1 		$30.1M Buy
+2,260,398
New +$21.2M 0.52% 39
2018
Q3 		– Sell
-11,959
Closed -$6.39M – 112
2018
Q2 		$6.39M Buy
+11,959
New +$3.68M 0.22% 93

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deerfield Management's SLDB Position: Q3 2024 in Review

Deerfield Management sold out of Solid Biosciences (SLDB) in Q3 2024, closing a stake of 1,743,398 shares — an estimated $9.89M sold.

Deerfield Management first reported a position in SLDB in Q2 2018 and held it in 3 quarters. The position peaked at $30.1M in Q1 2024. 92 funds tracked by Wall St. Rank hold SLDB as of Q3 2024.

  • Deerfield Management reported no remaining Solid Biosciences position as of Q3 2024 after selling out during the quarter.
  • Deerfield Management sold 1,743,398 Solid Biosciences shares in Q3 2024, an estimated $9.89M.
  • Deerfield Management first reported a position in Solid Biosciences in Q2 2018 and held it in 3 quarters.
  • Deerfield Management's Solid Biosciences position peaked at $30.1M in Q1 2024.
  • 92 funds tracked by Wall St. Rank held Solid Biosciences as of Q3 2024.

Based on Deerfield Management's 13F filing for Q3 2024, filed 14 Nov 2024.